Skip to main content

Introducing EVO ICL Lens

The Latest Advancement in Vision Correction Surgery

At our eye care practice, we take pride in offering a variety of advanced vision correction options to ensure we find the best solution for you. Now, we are excited to introduce the EVO ICL Lens, which received FDA approval in the United States in March 2022 and is now available for our patients at Precision Eye Care.

What is the EVO ICL Lens?

The EVO ICL is an Implantable Collamer® Lens designed to provide sharp, clear vision. Similar to LASIK and PRK, the EVO ICL is a type of refractive surgery that corrects nearsightedness (myopia) and astigmatism. However, unlike these procedures, the ICL can correct a high degree of myopia without removing any corneal tissue or causing dry eye syndrome.

What makes the EVO ICL Lens unique is its composition. Made from Collamer, a biocompatible and flexible material, it works in harmony with your eye, providing a natural feel. Moreover, the lens is implanted through a quick, 20-to-30-minute procedure, which allows patients to experience a fast recovery and improved vision shortly after.


Benefits of the EVO ICL Lens

  • Can correct or reduce nearsightedness for a wide range of vision, including patients with prescriptions up to -20 diopters and astigmatism between 1.0 D to 4.0 D.
  • Moreover, it provides excellent night vision.³
  • Additionally, it is suitable for patients with dry eye concerns.⁴
  • It is also a great option for patients with thin corneas, who may not be candidates for other vision correction procedures.
  • Designed for permanent vision correction, yet removable by a doctor if needed.
  • Furthermore, it offers UV protection.
  • Once in place, you will neither feel nor see the lens.
  • The procedure takes only 20 to 30 minutes, and recovery is quick.

Is the EVO ICL the Right Vision Correction Option for You?

If you are seeking freedom from glasses or contact lenses, the EVO ICL may be right for you. Potential candidates are:

  • Between the ages of 21 and 45.
  • Seeking treatment for nearsightedness (with or without astigmatism).
  • Moreover, they should have a stable prescription for at least one year.
  • Not currently pregnant or nursing.

Know Your Options

The decision to have vision correction surgery is an important one. That is why this compares the three most common corrective eye procedures: EVO ICL, LASIK, and PRK. We look forward to discussing your options with you.

Refractive Surgery Options

EVO ICL

The EVO ICL (Implantable Collamer Lens) is an implant that corrects vision without removing any corneal tissue.

LASIK

LASIK is a two-step laser vision correction surgery. First, a flap is made on the surface of the eye, called the cornea. Then, the underlying layers are reshaped with an excimer laser to correct vision.

PRK

PRK is a laser vision procedure similar to LASIK; however, no corneal flap is created. Instead, the top layer of the cornea, called the epithelium, is removed. Then, the underlying tissue is reshaped to correct vision.

Contact Us

Interested in learning more about vision correction with the EVO ICL Lens?

A consultation appointment is the best way to determine if it is the right option for you. Additionally, it provides an opportunity to get answers to any questions you may have about achieving your best possible vision, without the hassles of glasses or contact lenses. Therefore, contact us today!

———

References: (1) Martínez-Plaza E, López-Miguel A, López-de la Rosa  A, et al. Effect of the EVO+ Visian Phakic Implantable Collamer Lens on Visual Performance and Quality of Vision and Life, Am J Ophthalmol 2021;226:117-125. (2) Packer M. Evaluation of the EVO/EVO+ Sphere and Toric Visian ICL: Six month results from the United States Food and Drug Administration clinical trial. Clinical Ophthalmology. 2022;16:1541-53. (3) Parkhurst G. A prospective comparison of phakic Collamer lenses and wavefront-optimized laser-assisted in situ keratomileusis for correction of myopia. Clinical Ophthalmology. 2016. (4) Naves J, et al.. Diadenosine nucleotide measurements as dry-eye score in patients after LASIK and ICL surgery. Presented at American Society of Cataract and Refractive Surgery (ASCRS) 2012.

This will close in 23 seconds